Split History
ETFs Holding ALQA »    ALQA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alliqua BioMedical is a technologies company that commercializes differentiated regenerative medical products which assist the body in the repair of human tissue. Co.'s subsidiary, Celleration, Inc. developed the MIST® Ultrasound Healing Therapy (MIST Therapy) therapeutic ultrasound platform for the treatment of acute and chronic wounds. MIST Therapy is a noncontact, low-frequency ultrasound delivered through a saline mist to the wound bed. Co. has a license in intellectual property related to certain placental based products for wound care and wound management, including those made from extracellular matrix derived from the human placenta, and Biovance® Amniotic Membrane Allograft. According to our ALQA split history records, Alliqua BioMedical has had 1 split.
ALQA split history picture
Alliqua BioMedical (ALQA) has 1 split in our ALQA split history database. The split for ALQA took place on October 06, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of ALQA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Alliqua BioMedical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ALQA split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alliqua BioMedical shares, starting with a $10,000 purchase of ALQA, presented on a split-history-adjusted basis factoring in the complete ALQA split history. ALQA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/20/2009
End date: 02/19/2019
Start price/share: $2.70
End price/share: $2.24
Dividends collected/share: $0.00
Total return: -17.04%
Average Annual Total Return: -1.85%
Starting investment: $10,000.00
Ending investment: $8,296.23
Years: 10.00
Date Ratio
10/06/20171 for 10
ALQA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ALR Split History
ALT Split History
ALXA Split History
ALXN Split History
AMDA Split History
AMED Split History
AMGN Split History
AMN Split History
AMPE Split History
AMRI Split History

Also explore: ALQA shares outstanding history

Trovagene, Inc. (TROV)
Celldex Therapeutics, Inc. (CLDX)
Pulmatrix, Inc. (PULM)
Titan Pharmaceuticals, Inc. (TTNP)
SPORTSCENE GROUP INC. (SPS.A.CA)
Bio-Path Holdings, Inc. (BPTH)
Enghouse Systems Limited (ENGH.CA)
Camber Energy, Inc. (CEI)
IRET (IRET)
Diffusion Pharmaceuticals Inc. (DFFN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ALQA Insider Buying

ALQA Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.